Published in Contraception on April 05, 2007
Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis (2011) 10.96
Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies. Lancet Infect Dis (2015) 2.40
Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS (2010) 2.23
Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis. PLoS Med (2011) 1.89
Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanisms. Endocrinology (2013) 1.81
Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis. PLoS Med (2015) 1.61
Intravaginal practices, vaginal infections and HIV acquisition: systematic review and meta-analysis. PLoS One (2010) 1.47
Trichomoniasis and HIV interactions: a review. Sex Transm Infect (2013) 1.36
Women and HIV in Sub-Saharan Africa. AIDS Res Ther (2013) 1.20
Broadening the debate over HIV and hormonal contraception. Lancet Infect Dis (2015) 1.19
Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs. Contraception (2014) 1.15
Modelling the global competing risks of a potential interaction between injectable hormonal contraception and HIV risk. AIDS (2013) 1.11
Modeling the impact of Trichomonas vaginalis infection on HIV transmission in HIV-infected individuals in medical care. Sex Transm Dis (2012) 1.10
Maximizing the impact of HIV prevention efforts: interventions for couples. AIDS Care (2013) 0.99
Sustained High HIV Incidence in Young Women in Southern Africa: Social, Behavioral, and Structural Factors and Emerging Intervention Approaches. Curr HIV/AIDS Rep (2015) 0.97
Hormonal contraception is associated with a reduced risk of bacterial vaginosis: a systematic review and meta-analysis. PLoS One (2013) 0.94
Use of injectable progestin contraception and risk of STI among South African women. Contraception (2009) 0.93
Population-level impact of hormonal contraception on incidence of HIV infection and pregnancy in women in Durban, South Africa. Bull World Health Organ (2012) 0.90
An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women. AIDS (2016) 0.88
Contraceptive methods and risk of HIV acquisition or female-to-male transmission. Curr HIV/AIDS Rep (2014) 0.88
Contraception and HIV infection in women. Hum Reprod Update (2008) 0.85
Living with uncertainty: acting in the best interests of women. AIDS Res Treat (2012) 0.84
The Role of Sexually Transmitted Infections in HIV-1 Progression: A Comprehensive Review of the Literature. J Sex Transm Dis (2013) 0.83
Medroxyprogesterone acetate impairs human dendritic cell activation and function. Hum Reprod (2015) 0.81
Medroxyprogesterone acetate differentially regulates interleukin (IL)-12 and IL-10 in a human ectocervical epithelial cell line in a glucocorticoid receptor (GR)-dependent manner. J Biol Chem (2014) 0.78
Lower concentrations of chemotactic cytokines and soluble innate factors in the lower female genital tract associated with the use of injectable hormonal contraceptive. J Reprod Immunol (2015) 0.77
The role of dendritic cells in driving genital tract inflammation and HIV transmission risk: are there opportunities to intervene? Innate Immun (2013) 0.77
Could misreporting of condom use explain the observed association between injectable hormonal contraceptives and HIV acquisition risk? Contraception (2016) 0.75
Uptake of hormonal contraceptives and correlates of uptake in a phase III clinical trial in rural South Western Uganda. Reprod Health (2017) 0.75
Hormonal Contraception and HIV/AIDS Transmission: Challenges for Zimbabwe's Reproductive Health Service Providers in Promoting Informed Contraception Choices. J Public Health Africa (2013) 0.75
Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med (2008) 17.12
Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet (2002) 11.02
Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis (2011) 10.96
Short-course antiretroviral therapy in primary HIV infection. N Engl J Med (2013) 4.82
Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet (2010) 4.23
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet (2010) 3.90
Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study. PLoS One (2009) 3.66
Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples. AIDS (2011) 3.61
New regimens to prevent tuberculosis in adults with HIV infection. N Engl J Med (2011) 3.46
Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. AIDS (2009) 3.06
Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa. AIDS (2009) 2.97
Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa. PLoS Med (2011) 2.80
Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study. PLoS Med (2011) 2.76
The optimal delivery of palliative care: a national comparison of the outcomes of consultation teams vs inpatient units. Arch Intern Med (2011) 2.48
Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk. PLoS One (2010) 2.48
Heterosexual anal intercourse increases risk of HIV infection among young South African men. AIDS (2006) 2.34
A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers. AIDS (2005) 2.24
Prevalence and patterns of gender-based violence and revictimization among women attending antenatal clinics in Soweto, South Africa. Am J Epidemiol (2004) 2.17
Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med (2012) 2.06
A tale of two countries: rethinking sexual risk for HIV among young people in South Africa and the United States. J Adolesc Health (2011) 2.00
High incidence of unplanned pregnancy after antiretroviral therapy initiation: findings from a prospective cohort study in South Africa. PLoS One (2012) 1.96
Safety and tolerability of vaginal PRO 2000 gel in sexually active HIV-uninfected and abstinent HIV-infected women. AIDS (2003) 1.95
HIV and pregnancy. BMJ (2007) 1.90
Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines. Cancer Biol Ther (2003) 1.88
Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine. J Acquir Immune Defic Syndr (2007) 1.87
Knowledge and attitudes towards HIV vaccines among Soweto adolescents. BMC Res Notes (2008) 1.72
Linking the global positioning system (GPS) to a personal digital assistant (PDA) to support tuberculosis control in South Africa: a pilot study. Int J Health Geogr (2006) 1.71
Body mass index and risk of tuberculosis and death. AIDS (2010) 1.71
Effect of HIV on women. AIDS Read (2006) 1.65
Why are women still aborting outside designated facilities in metropolitan South Africa? BJOG (2005) 1.60
"You must do the test to know your status": attitudes to HIV voluntary counseling and testing for adolescents among South African youth and parents. Health Educ Behav (2006) 1.59
The ethics of nurse poaching from the developing world. Nurs Ethics (2003) 1.57
Combining PMTCT with active case finding for tuberculosis. J Acquir Immune Defic Syndr (2006) 1.56
Test and tell: correlates and consequences of testing and disclosure of HIV status in South Africa (HPTN 043 Project Accept). J Acquir Immune Defic Syndr (2009) 1.53
Web and telecounselling in Australia. Med J Aust (2004) 1.50
Large-scale affordable PanLeucogated CD4+ testing with proactive internal and external quality assessment: in support of the South African national comprehensive care, treatment and management programme for HIV and AIDS. Cytometry B Clin Cytom (2008) 1.50
Early coital debut and associated HIV risk factors among young women and men in South Africa. Int Perspect Sex Reprod Health (2009) 1.49
Costs of providing care for HIV-infected adults in an urban HIV clinic in Soweto, South Africa. J Acquir Immune Defic Syndr (2009) 1.49
The impact of age on the epidemiology of incomplete abortions in South Africa after legislative change. BJOG (2005) 1.49
Safety and efficacy of initiating highly active antiretroviral therapy in an integrated antenatal and HIV clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr (2008) 1.46
Geographic distribution of human immunodeficiency virus in South Africa. Am J Trop Med Hyg (2007) 1.45
Dramatic decline in abortion mortality due to the Choice on Termination of Pregnancy Act. S Afr Med J (2005) 1.44
Continued high risk sexual behavior following diagnosis with acute HIV infection in South Africa and Malawi: implications for prevention. AIDS Behav (2011) 1.41
The reliability of point-of-care CD4 testing in identifying HIV-infected pregnant women eligible for antiretroviral therapy. J Acquir Immune Defic Syndr (2012) 1.40
Validation of a core outcome measure for palliative care in Africa: the APCA African Palliative Outcome Scale. Health Qual Life Outcomes (2010) 1.40
Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants. J Infect Dis (2010) 1.39
Prevalence of parental death among young people in South Africa and risk for HIV infection. J Acquir Immune Defic Syndr (2007) 1.38
Couples at risk: HIV-1 concordance and discordance among sexual partners receiving voluntary counseling and testing in Uganda. J Acquir Immune Defic Syndr (2005) 1.36
The prevalence and burden of symptoms amongst cancer patients attending palliative care in two African countries. Eur J Cancer (2010) 1.35
Analysis of genetic bottlenecks during horizontal transmission of Cucumber mosaic virus. J Virol (2006) 1.34
Progression and regression of premalignant cervical lesions in HIV-infected women from Soweto: a prospective cohort. AIDS (2011) 1.32
A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine. Breast Cancer Res Treat (2003) 1.32
Tuberculosis active case-finding in a mother-to-child HIV transmission prevention programme in Soweto, South Africa. AIDS (2003) 1.29
Twenty-five years' clinical experience with placental site trophoblastic tumors. J Reprod Med (2002) 1.25
Contraceptive method and pregnancy incidence among women in HIV-1-serodiscordant partnerships. AIDS (2012) 1.24
Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study. J Int AIDS Soc (2011) 1.22
Relationship between self-efficacy and physical activity among patients with type 2 diabetes. J Behav Med (2009) 1.20
The 'healthy brothel': the context of clinical services for sex workers in Hillbrow, South Africa. Cult Health Sex (2006) 1.16
Novel strategies implemented to ensure high participant retention rates in a community based HIV prevention effectiveness trial in South Africa and Zimbabwe. Contemp Clin Trials (2009) 1.15
Are targeted HIV prevention activities cost-effective in high prevalence settings? Results from a sexually transmitted infection treatment project for sex workers in Johannesburg, South Africa. Sex Transm Dis (2006) 1.14
Managing men: women's dilemmas about overt and covert use of barrier methods for HIV prevention. Cult Health Sex (2009) 1.13
Estimating the public health impact of the effect of herpes simplex virus suppressive therapy on plasma HIV-1 viral load. AIDS (2009) 1.11
Increased microbial translocation in ≤ 180 days old perinatally human immunodeficiency virus-positive infants as compared with human immunodeficiency virus-exposed uninfected infants of similar age. Pediatr Infect Dis J (2011) 1.11
Frequent emergence of N348I in HIV-1 subtype C reverse transcriptase with failure of initial therapy reduces susceptibility to reverse-transcriptase inhibitors. Clin Infect Dis (2012) 1.11
The importance of context: model projections on how microbicide impact could be affected by the underlying epidemiologic and behavioral situation in 2 African settings. Sex Transm Dis (2006) 1.10
Consistent condom use in South African youth's most recent sexual relationships. AIDS Behav (2008) 1.08
Optimization of allele-specific PCR using patient-specific HIV consensus sequences for primer design. J Virol Methods (2009) 1.08
Cross-sectional study of genital, rectal, and pharyngeal Chlamydia and gonorrhea in women in rural South Africa. Sex Transm Dis (2014) 1.08
Transmission rates in consecutive pregnancies exposed to single-dose nevirapine in Soweto, South Africa and Abidjan, Côte d'Ivoire. J Acquir Immune Defic Syndr (2007) 1.08
Improvement in healing and reduction in HIV shedding with episodic acyclovir therapy as part of syndromic management among men: a randomized, controlled trial. J Infect Dis (2009) 1.08
Predictors of persistent cytologic abnormalities after treatment of cervical intraepithelial neoplasia in Soweto, South Africa: a cohort study in a HIV high prevalence population. BMC Cancer (2008) 1.07
Women's perceptions and experiences of HIV prevention trials in Soweto, South Africa. Soc Sci Med (2007) 1.05
Monitoring HIV antiretroviral therapy in resource-limited settings: time to avoid costly outcomes. Clin Infect Dis (2009) 1.05
Circumcision for prevention against HIV: marked seasonal variation in demand and potential public sector readiness in Soweto, South Africa. Implement Sci (2007) 1.05
Controlling the HIV epidemic with antiretrovirals: IAPAC consensus statement on treatment as prevention and preexposure prophylaxis. J Int Assoc Provid AIDS Care (2013) 1.04
PEPFAR's evolving HIV prevention approaches for key populations--people who inject drugs, men who have sex with men, and sex workers: progress, challenges, and opportunities. J Acquir Immune Defic Syndr (2012) 1.04
Assessment of service availability and health care workers' opinions about young women's sexual and reproductive health in Soweto, South Africa. Afr J Reprod Health (2012) 1.04
CD8/CD38 activation yields important clinical information of effective antiretroviral therapy: findings from the first year of the CIPRA-SA cohort. Cytometry B Clin Cytom (2008) 1.03
Prevalence, burden, and correlates of physical and psychological symptoms among HIV palliative care patients in sub-Saharan Africa: an international multicenter study. J Pain Symptom Manage (2012) 1.03
Preferences for characteristics of antiretroviral therapy provision in Johannesburg, South Africa: results of a conjoint analysis. AIDS Behav (2009) 1.03
Prevalence of morbidity associated with abortion before and after legalisation in South Africa. BMJ (2002) 1.01
HIV and sexual behavior among young people: the South African paradox. Sex Transm Dis (2008) 1.01
Predicting the impact of a partially effective HIV vaccine and subsequent risk behavior change on the heterosexual HIV epidemic in low- and middle-income countries: A South African example. J Acquir Immune Defic Syndr (2007) 1.00
Quality of life among patients receiving palliative care in South Africa and Uganda: a multi-centred study. Health Qual Life Outcomes (2011) 1.00
Women exposed to single-dose nevirapine in successive pregnancies: effectiveness and nonnucleoside reverse transcriptase inhibitor resistance. AIDS (2009) 1.00
The prevalence and burden of pain and other symptoms among South Africans attending highly active antiretroviral therapy (HAART) clinics. S Afr Med J (2012) 0.99
Families' perceptions of end-of-life care in Veterans Affairs versus non-Veterans Affairs facilities. J Palliat Med (2010) 0.99
Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda. Vaccine (2013) 0.99
Investing in the future: lessons learnt from communicating the results of HSV/ HIV intervention trials in South Africa. Health Res Policy Syst (2011) 0.98
A case study of antenatal syphilis screening in South Africa: successes and challenges. Sex Transm Dis (2002) 0.98